<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04652388</url>
  </required_header>
  <id_info>
    <org_study_id>353/20</org_study_id>
    <nct_id>NCT04652388</nct_id>
  </id_info>
  <brief_title>Impact of Nutritional Counselling in Children With Autism</brief_title>
  <official_title>The Impact of Nutritional Counselling in Children With Autistic Spectrum Disorder</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Federico II University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Federico II University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Autism Spectrum Disorder (ASD) is a complex group of behavioral disorders characterized by&#xD;
      defects in social interaction and communication associated with restricted and repetitive&#xD;
      behaviors and activities. The prevalence in pediatric age is continuously increasing in&#xD;
      Western countries (58-67 / 10,000). The Diagnostic and Statistical Manual of Mental Disorders&#xD;
      version 5 (DSM-5) describes a worldwide population prevalence of approximately 1%. According&#xD;
      to the latest data from the National Observatory for the monitoring of ASD, in Italy 1 child&#xD;
      out of 77 (age 7-9 years) has the disease with a higher prevalence in males: males are&#xD;
      affected 4.4 times more than females . The clinical manifestations of ASD are the result of&#xD;
      complex interactions between genetic, epigenetic, environmental and microbiological factors.&#xD;
      Alterations in nutritional status, eating habits and adverse reactions to food appear to be&#xD;
      more frequent in children with ASD. It is estimated that 46-89% of children with ASD have&#xD;
      feeding problems which can include unusual eating patterns, rituals and food selectivity.&#xD;
      These types of eating behaviors can lead to severe alterations in nutritional status.&#xD;
      Furthermore, the data present in the literature concerning the eating habits of children with&#xD;
      ASD suggest a high consumption of &quot;junk food&quot; and foods rich in calories together with a&#xD;
      refusal of fruit, vegetables or proteins. These data suggest that the dietary and behavioral&#xD;
      problems frequently present in these children could favor a condition of obesity. Finally, a&#xD;
      high percentage of children with ASD undergo elimination diets, characterized by exclusions&#xD;
      of foods relevant to the diet of a child such as milk and gluten to alleviate the symptoms of&#xD;
      the disease. Such elimination diets are only rarely supervised by a nutritionist with further&#xD;
      consequences on nutritional status.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 1, 2020</start_date>
  <completion_date type="Anticipated">September 1, 2022</completion_date>
  <primary_completion_date type="Actual">September 1, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Adherence to Mediterranean Diet</measure>
    <time_frame>change from baseline at 12 months</time_frame>
    <description>Evaluation of mediterranea diet through score aiming to assess the mediterranean diet adhesion (Kidmed score; minimum value 0-worse maximum value 12-better)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in food selectivity</measure>
    <time_frame>change from baseline at 12 months</time_frame>
    <description>Evaluation of Food Preferences Inventory score (cut off 47; &lt;47 selective child)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in eating habits</measure>
    <time_frame>change from baseline at 12 months</time_frame>
    <description>Evaluation of 3-day diary foods</description>
  </secondary_outcome>
  <other_outcome>
    <measure>change in auxological parameters</measure>
    <time_frame>change from baseline at 12 months</time_frame>
    <description>Evaluation of body growth, height</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Autism Spectrum Disorder</condition>
  <arm_group>
    <arm_group_label>Nutritional counseling</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Children with autism spectrum disorders to whom administer nutritional counseling</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Controls</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>No intervention</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Nutritional counseling</intervention_name>
    <description>Nutritional counseling about mediterranean diet</description>
    <arm_group_label>Nutritional counseling</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  diagnosis of autism spectrum disorders&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Age at enrollment &lt;24 or&gt; 48 months.&#xD;
&#xD;
          -  Concomitant presence of other chronic diseases&#xD;
&#xD;
          -  epilepsy,&#xD;
&#xD;
          -  neurological syndromes,&#xD;
&#xD;
          -  immunodeficiencies,&#xD;
&#xD;
          -  diabetes,&#xD;
&#xD;
          -  congenital heart disease,&#xD;
&#xD;
          -  autoimmune diseases,&#xD;
&#xD;
          -  inborn errors of metabolism,&#xD;
&#xD;
          -  tuberculosis,&#xD;
&#xD;
          -  cystic fibrosis,&#xD;
&#xD;
          -  chronic respiratory tract diseases,&#xD;
&#xD;
          -  inflammatory bowel disease,&#xD;
&#xD;
          -  celiac disease,&#xD;
&#xD;
          -  eosinophilic pathologies of the gastrointestinal tract,&#xD;
&#xD;
          -  functional gastrointestinal disorders,&#xD;
&#xD;
          -  obesity,&#xD;
&#xD;
          -  tumors,&#xD;
&#xD;
          -  malnutrition â€¢ Major malformations or previous surgery of the gastrointestinal /&#xD;
             urinary / respiratory tract.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>24 Months</minimum_age>
    <maximum_age>48 Months</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>University of Naples Federico II</name>
      <address>
        <city>Naples</city>
        <zip>80131</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Roberto Berni Canani</last_name>
      <phone>0817462680</phone>
      <email>berni@unina.it</email>
    </contact>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>December 2020</verification_date>
  <study_first_submitted>November 23, 2020</study_first_submitted>
  <study_first_submitted_qc>December 2, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">December 3, 2020</study_first_posted>
  <last_update_submitted>December 2, 2020</last_update_submitted>
  <last_update_submitted_qc>December 2, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">December 3, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Federico II University</investigator_affiliation>
    <investigator_full_name>Roberto Berni Canani</investigator_full_name>
    <investigator_title>Chief of the Pediatric Allergy Program at the Department of Translational Medical Science Chief of the ImmunoNutritionLab at CEINGE - Advanced Biotechnologies</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Autism Spectrum Disorder</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

